Skip to content
  • Saturday, 15 August 2026
  • 12:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 23, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, classified psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jul 15, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 8, 2026 0

The landscape of mental health treatment is on the cusp of a profound transformation, with psilocybin, a compound once relegated…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jun 30, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
UC San Diego Researchers Unveil High-Efficiency Piezoelectric Hybrid Power Converters to Address Escalating Energy Demands in Modern Data CentersLandmark Research Reveals How Aging Sperm Accumulate Harmful Genetic Mutations Through Internal Natural SelectionPeptides are unproven as health aids. FDA may unleash them anywayPrenatal Estrogen Exposure and the Evolution of the Human Brain: Insights from Digit Ratio and Neonatal Head Circumference
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ